These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 27425245)

  • 1. The selective glucocorticoid receptor agonist mapracorat displays a favourable safety-efficacy ratio for the topical treatment of inflammatory skin diseases in dogs.
    Bäumer W; Rossbach K; Schmidt BH
    Vet Dermatol; 2017 Feb; 28(1):46-e11. PubMed ID: 27425245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eosinophil as a cellular target of the ocular anti-allergic action of mapracorat, a novel selective glucocorticoid receptor agonist.
    Baiula M; Spartà A; Bedini A; Carbonari G; Bucolo C; Ward KW; Zhang JZ; Govoni P; Spampinato S
    Mol Vis; 2011; 17():3208-23. PubMed ID: 22194647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo ocular efficacy profile of mapracorat, a novel selective glucocorticoid receptor agonist, in rabbit models of ocular disease.
    Shafiee A; Bucolo C; Budzynski E; Ward KW; López FJ
    Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1422-30. PubMed ID: 20881303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapracorat, a selective glucocorticoid receptor agonist, causes apoptosis of eosinophils infiltrating the conjunctiva in late-phase experimental ocular allergy.
    Baiula M; Bedini A; Baldi J; Cavet ME; Govoni P; Spampinato S
    Drug Des Devel Ther; 2014; 8():745-57. PubMed ID: 24959069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapracorat, a novel non-steroidal selective glucocorticoid receptor agonist for the treatment of allergic conjunctivitis.
    Baiula M; Spampinato S
    Inflamm Allergy Drug Targets; 2014; 13(5):289-98. PubMed ID: 25373600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular pharmacokinetics of mapracorat, a novel, selective glucocorticoid receptor agonist, in rabbits and monkeys.
    Proksch JW; Lowe ER; Ward KW
    Drug Metab Dispos; 2011 Jul; 39(7):1181-7. PubMed ID: 21441467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapracorat, a selective glucocorticoid receptor agonist, upregulates RelB, an anti-inflammatory nuclear factor-kappaB protein, in human ocular cells.
    Spinelli SL; Xi X; McMillan DH; Woeller CF; Richardson ME; Cavet ME; Zhang JZ; Feldon SE; Phipps RP
    Exp Eye Res; 2014 Oct; 127():290-8. PubMed ID: 25245083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-allergic effects of mapracorat, a novel selective glucocorticoid receptor agonist, in human conjunctival fibroblasts and epithelial cells.
    Cavet ME; Volhejn S; Harrington KL; Zhang JZ
    Mol Vis; 2013; 19():1515-25. PubMed ID: 23878502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases.
    Schäcke H; Zollner TM; Döcke WD; Rehwinkel H; Jaroch S; Skuballa W; Neuhaus R; May E; Zügel U; Asadullah K
    Br J Pharmacol; 2009 Oct; 158(4):1088-103. PubMed ID: 19422381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inflammatory effects of mapracorat, a novel selective glucocorticoid receptor agonist, is partially mediated by MAP kinase phosphatase-1 (MKP-1).
    Vollmer TR; Stockhausen A; Zhang JZ
    J Biol Chem; 2012 Oct; 287(42):35212-35221. PubMed ID: 22898817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapracorat, a novel selective glucocorticoid receptor agonist, inhibits hyperosmolar-induced cytokine release and MAPK pathways in human corneal epithelial cells.
    Cavet ME; Harrington KL; Ward KW; Zhang JZ
    Mol Vis; 2010 Sep; 16():1791-800. PubMed ID: 20824100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized trial of pimecrolimus cream versus triamcinolone acetonide paste in the treatment of oral lichen planus.
    Gorouhi F; Solhpour A; Beitollahi JM; Afshar S; Davari P; Hashemi P; Nassiri Kashani M; Firooz A
    J Am Acad Dermatol; 2007 Nov; 57(5):806-13. PubMed ID: 17658663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple-center study of reduced-concentration triamcinolone topical solution for the treatment of dogs with known or suspected allergic pruritus.
    Deboer DJ; Schafer JH; Salsbury CS; Blum JR; Beale KM; Vitale CB; Muse R; Moriello KA; Garfield RA; Keefe TJ; McArthur TR
    Am J Vet Res; 2002 Mar; 63(3):408-13. PubMed ID: 11911576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Occlusive and Open Application in a Psoriasis Plaque Test Design, Exemplarily Using Investigations of Mapracorat 0.1% Ointment versus Vehicle and Reference Drugs.
    Wigger-Alberti W; Williams R; von Mackensen YL; Hoffman-Wecker M; Grossmann U; Staedtler G; Nkulikiyinka R; Shakery K
    Skin Pharmacol Physiol; 2017; 30(2):102-114. PubMed ID: 28407625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of canine atopic dermatitis: 2010 clinical practice guidelines from the International Task Force on Canine Atopic Dermatitis.
    Olivry T; DeBoer DJ; Favrot C; Jackson HA; Mueller RS; Nuttall T; Prélaud P;
    Vet Dermatol; 2010 Jun; 21(3):233-48. PubMed ID: 20456716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of treatment with triamcinolone acetonide in calcinosis cutis following extravasation of calcium gluconate: a preliminary study.
    Ahn SK; Kim KT; Lee SH; Hwang SM; Choi EH; Choi S
    Pediatr Dermatol; 1997; 14(2):103-9. PubMed ID: 9144694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ocular effects of intravitreal triamcinolone acetonide in dogs.
    Molleda JM; Tardón RH; Gallardo JM; Martín-Suárez EM
    Vet J; 2008 Jun; 176(3):326-32. PubMed ID: 17466546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical 'dual-soft' glucocorticoid receptor agonist for dermatology.
    Dack KN; Johnson PS; Henriksson K; Eirefelt S; Carnerup MA; Stahlhut M; Ollerstam AK
    Bioorg Med Chem Lett; 2020 Sep; 30(17):127402. PubMed ID: 32738970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of canine atopic dermatitis: 2015 updated guidelines from the International Committee on Allergic Diseases of Animals (ICADA).
    Olivry T; DeBoer DJ; Favrot C; Jackson HA; Mueller RS; Nuttall T; Prélaud P;
    BMC Vet Res; 2015 Aug; 11():210. PubMed ID: 26276051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of palmitoylethanolamide on the cutaneous allergic inflammatory response in Ascaris hypersensitive Beagle dogs.
    Cerrato S; Brazis P; Della Valle MF; Miolo A; Petrosino S; Di Marzo V; Puigdemont A
    Vet J; 2012 Mar; 191(3):377-82. PubMed ID: 21601500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.